Kenny–Caffey syndrome, type 1

Kenny-Caffey Syndrome, Type 1 (KCS1) is a rare, genetic disorder characterized by growth retardation, cortical thickening of the long bones, and transient hypocalcemia. This condition is part of a group of diseases that affect the development and function of bones. KCS1 is inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.

Symptoms and Characteristics

Kenny-Caffey Syndrome, Type 1 presents with a distinct set of clinical features. Key symptoms include:

• Growth Retardation: Individuals with KCS1 typically exhibit growth delays, resulting in short stature.
• Skeletal Abnormalities: Patients may have thickened cortices of the long bones, which can be detected through radiographic imaging.
• Hypocalcemia: Transient low calcium levels in the blood are common, which can lead to tetany or seizures in severe cases.
• Microcephaly: A condition where the head circumference is smaller than normal for an individual's age and sex.
• Ocular Anomalies: Some individuals may have eye abnormalities, including cataracts.

Genetics

Kenny-Caffey Syndrome, Type 1 is caused by mutations in the TBX1 gene. This gene plays a crucial role in the development of various tissues, including bones. Mutations in TBX1 disrupt normal bone growth and mineral metabolism, leading to the symptoms observed in KCS1. The condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Diagnosis

Diagnosis of Kenny-Caffey Syndrome, Type 1 is based on clinical evaluation and the presence of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the TBX1 gene. Radiographic imaging is also useful in detecting skeletal abnormalities associated with the syndrome.

Treatment

There is no cure for Kenny-Caffey Syndrome, Type 1, and treatment is symptomatic and supportive. Management may include:

• Calcium Supplementation: To address hypocalcemia and prevent seizures.
• Growth Hormone Therapy: May be considered to improve growth in some patients.
• Regular Monitoring: Regular follow-ups with a healthcare provider are essential to monitor growth, development, and calcium levels.

Prognosis

The prognosis for individuals with Kenny-Caffey Syndrome, Type 1 varies. With appropriate management, most of the complications, such as hypocalcemia, can be controlled. However, growth retardation and skeletal abnormalities are permanent.

See Also

• Hypocalcemia
• Growth Hormone Deficiency
• Genetic Disorders
• Bone Diseases

   This article is a  stub. You can help WikiMD by expanding it!